Fuertes Abardia C, Ballesta Juan P, Cruz Esteve I, Galindo Ortego G, Marsal Mora JR, Gomez-Arbones X. Potentially inappropriate prescribing: usefulness of STOPP/START criteria version 2 in Catalonian elderly population. Semergen. 2022 Apr;48(3):163-73. doi: 10.1016/j.semerg.2021.09.005
Montserrat-Capdevila J, Godoy P, Marsal JR, Ortega M, Pifarre J, Barbe F. Comorbidity in mental health in patients diagnosed with chronic obstructive pulmonary disease. Semergen. 2020 Jan;46(1):53-9. doi: 10.1016/j.semerg.2019.08.002
Kawai AT, Martinez D, Saltus CW, Vassilev ZP, Soriano-Gabarro M, Kaye JA. Incidence of skeletal-related events in patients with castration-resistant prostate cancer: an observational retrospective cohort study in the US. Prostate Cancer. 2019 Jul 9. doi: 10.1155/2019/5971615
Saltus CW, Vassilev ZP, Zong J, Calingaert B, Andrews EB, Soriano-Gabarro M, Kaye JA. Incidence of second primary malignancies in patients with castration-resistant prostate cancer: an observational retrospective cohort study in the United States. Prostate Cancer. 2019 Feb 11;2019:4387415. doi: 10.1155/2019/4387415
Luo C, Sun J, Liu D, Sun B, Miao L, Musetti S, Li J, Han X, Du Y, Li L, Huang L, He Z. Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy. Nano Lett. 2016 Sep 14;16(9):5401-8. doi: 10.1021/acs.nanolett.6b01632